Diet modulates the toxicity of cancer chemotherapy in rats

Journal of Laboratory and Clinical Medicine

Volumn 140, Issue 5, 2002, Pages 358-368

  Branda, Richard F ^a   Chen, Zhuan ^a   Brooks, Elice M ^a   Naud, Shelly J ^a   Trainer, Thomas D ^a   McCormack, John J ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0036847008     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1067/mlc.2002.128648     Document Type: Article

References (44)

1. Anthony AC. Megaloblastic anemias. In: Hoffman R, Benz EJ, Shattil SJ, et al, editors. Hematology: Basic Principles and Practice. New York: Churchill Livingstone, 1991:392-422.
2. Branda RF, Blickensderfer DB. Folate deficiency increases genetic damage caused by alkylating agents and γ-irradiation in Chinese hamster ovary cells. Cancer Res 1993;53:5401-8.
3. Melnyk S, Pogribna M, Miller BJ, Basnakian AG, Pogribny IP, James SJ. Uracil misincorporation, DNA strand breaks, and gene amplification are associated with tumorigenic cell transformation in folate deficient/repleted Chinese hamster ovary cells. Cancer Lett 1999;146:35-44.
4. Kim YI, Pogribny IP, Basnakian AG, Miller JW, Selhub J, James SJ, et al. Folate deficiency in rats induces DNA strand breaks and hypomethylation within the p53 tumor suppressor gene. Am J Clin Nutr 1997;65:46-52.
5. Duthie SJ, Hawdon A. DNA instability (strand breakage, uracil misincorporation, and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 1998;12: 1491-7.
6. Heath CW. Cytogenetic observations in vitamin B12 and folate deficiency. Blood 1966;27:800-15.
7. Libbus BL, Borman LS, Ventrone CH, Branda RF. Nutritional folate-deficiency in Chinese hamster ovary cells: Chromosomal abnormalities associated with perturbations in nucleic acid precursors. Cancer Genet Cytogenet 1990;46:231-42.
8. Choi SW, Kim YI, Weitzel JN, Mason JB. Folate depletion impairs DNA excision repair in the colon of the rat. Gut 1998; 43:93-9.
9. Branda RF, Hacker M, Lafayette A, Nigels E, Sullivan LM, Nicklas JA, et al. Nutritional folate deficiency augments the in vivo mutagenic and lymphocytotoxic activities of alkylating agents. Environ Mol Mutagen 1998;32:33-8.
10. Branda RF, O'Neill JP, Brooks EM, Trombley LM, Nicklas JA. The effect of folate deficiency on the cytotoxic and mutagenic responses to ethyl methanesulfonate in human lymphoblastoid ceil lines that differ in P53 status. Mutation Res 2001;473:51-71.
11. Branda RF, O'Neill JP, Sullivan LM, Albertini RJ. Factors influencing mutation at the hprt locus in T-lymphocytes: Women treated for breast cancer. Cancer Res 1991;51:6603-7.
12. Branda RF, Lafayette AR, O'Neill JP, Nicklas JA. The effect of folate deficiency on the hprt mutational spectrum in Chinese hamster ovary cells treated with monofunctional alkylating agents. Mutat Res 1999;427:79-87.
13. Iyer L, Ratain MJ. 5-fluorouracil pharmacokinetics: Causes for variability and strategies for modulation in cancer chemotherapy. Cancer Invest 1999;17:494-506.
14. Grogan L, Sotos GA, Allegra CJ. Leucovorin modulation of fluorouracil. Oncology 1993;7:63-71.
15. Raghunathan K, Priest DG. Modulation of fluorouracil antitumor activity by folic acid in a murine model system. Biochem Pharmacol 1999;58:835-9.
16. O'Connell MJ. A controlled clinical trial including folinic acid at two distinct dose levels in combination with 5-fluorouracil (5FU) for the treatment of advanced colorectal cancer: Experience of the Mayo Clinic and North Central Cancer Treatment Group. In: Rustum Y, McGuire JJ, editors. The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy. New York: Plenum Press, 1988:173-83.
17. Branda RF, Nigels E, Lafayette AR, Hacker M. Nutritional folate status influences the efficacy and toxicity of chemotherapy in rats. Blood 1998;92:2471-6.
18. Reeves PG, Nielsen FH, Fahey GC. AIN-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.
19. Tamura T. Microbiological assay of folates. In: Picciano MF, Stokstad EL, Gregory JF, editors. Folic Acid Metabolism in Health and Disease. New York: Wiley-Liss, 1990:121-37.
20. Wilson SD, Home DW. Use of glycerol-cryoprotected Lactobacillus casei for microbiological assay of folic acid. Clin Chem 1982;28:1198-1200.
21. Shapiro BH, MacLeod JN, Pampori NA, Morrissey JJ, Lapenson DP, Waxman DJ. Signaling elements in the ultradian rhythm of circulating growth hormone regulating expression of sex-dependent forms of hepatic cytochrome P450. Endocrinology 1989; 125:2935-44.
22. Estabrook RW, Peterson J, Baron J, Hildebrandt A. The spectrophotometric measurement of turbid suspensions of cytochromes associated with drug metabolism. In: Chignell CF, editor. Methods in Pharmacology (vol 2). New York: Plenum Press, 1972:303-50.
23. Kohn FR, Landkamer GJ, Manthey CL, Ramsay NKC, Sladek NE. Effect of aldehyde dehydrogenase inhibitors on the ex vivo sensitivity of human multipotent and committed hematopoietic progenitor cells and malignant blood cells to oxazaphosphorines. Cancer Res 1987;47:3180-5.
24. Gallagher EP, Kavanagh TJ, Eaton DL. Glutathione, oxidized glutathione, and mixed disulfides in biological samples. In: Tyson CA, Frazier JM, editors, Methods in Toxicology, Volume 1, Part B, In Vitro Toxicity Indicators. San Diego: Academic Press, 1994:349-55.
25. Clamon GH. Alkylating Agents. In: Perry MC, editor. The Chemotherapy Source Book. Baltimore: Williams and Wilkins, 1992:286-300.
26. Schilsky RL. Antimetabolites. In: Perry MC, editor. The Chemotherapy Source Book. Baltimore: Williams and Wilkins, 1992:301-17.
27. Cohen SM, Masui T, Garland EM, Arnold LL. Effects of diet on urinary bladder carcinogenesis and cancer prevention. J Nutr 1997;127:826S-29.
28. Blakely SR, Rogers A, Hendrich S. Introduction: Animal diets for nutritional and toxicological research. J Nutr 1997;127:824S-25.
29. Bounous G, Pageau R, Regoli D. The role of diet on 5-fluorouracil toxicity. Int J Clin Pharmacol 1978:16:519-22.
30. Bounous G, Maestracci D. Use of an elemental diet in animals during treatment with 5-fluorouracil (NSC-19893). Cancer Treat Reports 1976;60:17-22.
31. Murgo AJ, Weinberger BB. Pharmacological bone marrow purging in autologous transplantation: Focus on the cyclophosphamide derivatives. Crit Rev Oncol Hematol 1993:14:41-60.
32. Ren S, Yang JS, Kalhorn TF, Slattery JT. Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes. Cancer Res 1997;57:4229-35.
33. Yu LJ, Drewes P, Gustafsson K, Brain EG, Hecht JE, Waxman DJ. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: Impact on pharmacokinetics and antitumor activity. J Pharmacol Exp Ther 1999;288:928-37.
34. Wattenberg LW. Effects of dietary constituents on the metabolism of chemical carcinogens. Cancer Res 1975;35:3326-31.
35. Dirven HA, van Ommen B, van Bladeren PJ. Glutathione conjugation of alkylating cytostatic drugs with a nitrogen mustard group and the role of glutathione S-transferases. Chem Res Toxicol 1996;9:351-60.
36. Adams DJ, Carmichael J, Wolf CR. Altered mouse bone marrow glutathione and glutathione transferase levels in response to cytotoxins. Cancer Res 1986;45:1669-73.
37. Henning SM, McKee RW, Swendseid ME. Hepatic content of S-adenosylmethionine, S-adenosylhomocysteine and glutathione in rats receiving treatments modulating methyl donor availability. J Nutr 1989;119:1478-82.
38. Durand P, Prost M, Blache D. Pro-thrombotic effects of a folic acid deficient diet in rat platelets and macrophages related to elevated homocysteine and decreased n-3 polyunsaturated fatty acids. Atherosclerosis 1996;121:231-43.
39. Jackson CD, Weis C, Miller BJ, James SJ. Dietary nucleotides: Effects on cell proliferation following partial hepatectomy in rats fed NIH-31, AIN-76A, or folate/methyl-deficient diets. J Nutr 1997;127:834S-7.
40. Aidoo A, Bishop M, Mittelsteadt RA, Lyn-Cook LE, Duffy P, Heflich RH. Influence of calorie restriction on lymphocyte HPRT mutant frequency in rats maintained on NIH-31 and semipurified AIN-93M diets. Environ Mol Mutagen 2000;35:9 (suppl)
41. Kinsella AR, Pickard M. Resistance to chemotherapeutic antimetabolites: A function of salvage pathway involvement and cellular response to DNA damage. Brit J Cancer 1997;75:935-45.
42. Morshed K, Ross DM, McMartin KE. Folate transport proteins mediate the bidirectional transport of 5-methyltetrahydrofolate in cultured human proximal tubule cells. J Nutr 1997;127:1137-47.
43. Schubert GE, Welte K, Otten G. Chronic folic acid nephropathy. Res Exp Med 1973;162:17-36.
44. Klingler EL, Evan AP, Anderson RE. Folic acid-induced renal injury and repair. Arch Pathol Lab Med 1980;104:87-93.